{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:36:33Z","timestamp":1777628193545,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 186103"],"award-info":[{"award-number":["PJT 186103"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-24-0037877"],"award-info":[{"award-number":["G-24-0037877"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.molpha.2025.100094","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:43:43Z","timestamp":1764315823000},"page":"100094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amiodarone irrecoverably impairs the function of human ether-a-go-go-related gene potassium channels"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8109-9143","authenticated-orcid":false,"given":"Illia","family":"Gelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reese","family":"Bogart-Cherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4781-4699","authenticated-orcid":false,"given":"Nicole","family":"Tomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4522-977X","authenticated-orcid":false,"given":"Neelakshi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Baranchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"El-Diasty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2297-0193","authenticated-orcid":false,"given":"Shetuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4065\/84.3.234","article-title":"Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis","volume":"84","author":"Doyle","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jjcc.2011.06.005","article-title":"Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure","volume":"58","author":"Kawabata","year":"2011","journal-title":"J Cardiol"},{"issue":"7","key":"10.1016\/j.molpha.2025.100094_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.163.7.777","article-title":"Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis","volume":"163","author":"Letelier","year":"2003","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-8703(85)90158-9","article-title":"Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness","volume":"110","author":"Flaker","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.molpha.2025.100094_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116513","article-title":"The ion channel basis of pharmacological effects of amiodarone on myocardial electrophysiological properties, a comprehensive review","volume":"174","author":"Gelman","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.molpha.2025.100094_bib6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/01.CIR.103.9.1317","article-title":"Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K+ current","volume":"103","author":"Kamiya","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.molpha.2025.100094_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(97)00114-4","article-title":"Cellular electropharmacology of amiodarone","volume":"35","author":"Kodama","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.molpha.2025.100094_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104521","article-title":"The role of amiodarone in contemporary management of complex cardiac arrhythmias","volume":"151","author":"Mujovi\u0107","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"issue":"7083","key":"10.1016\/j.molpha.2025.100094_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"issue":"5220","key":"10.1016\/j.molpha.2025.100094_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"HERG, a human inward rectifier in the voltage-gated potassium channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib12","doi-asserted-by":"crossref","first-page":"44B","DOI":"10.1016\/0002-9149(93)90040-J","article-title":"Current status of class III antiarrhythmic drug therapy","volume":"72","author":"Roden","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.molpha.2025.100094_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2013.08.010","article-title":"Dynamics of the late Na+ current during cardiac action potential and its contribution to afterdepolarizations","volume":"64","author":"Horvath","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"10.1016\/j.molpha.2025.100094_bib14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.RES.64.5.977","article-title":"Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current","volume":"64","author":"January","year":"1989","journal-title":"Circ Res"},{"issue":"19","key":"10.1016\/j.molpha.2025.100094_bib15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.100.19.2025","article-title":"Evidence-based analysis of amiodarone efficacy and safety","volume":"100","author":"Connolly","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.CIR.77.6.1395","article-title":"Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs","volume":"77","author":"Bailie","year":"1988","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.molpha.2025.100094_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-8703(89)90258-5","article-title":"Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers","volume":"118","author":"Kaseda","year":"1989","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.molpha.2025.100094_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1592\/phco.19.8.635.31528","article-title":"Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model","volume":"19","author":"White","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/bdd.2510060211","article-title":"Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy","volume":"6","author":"Marchiset","year":"1985","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"10.1016\/j.molpha.2025.100094_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.1982.57","article-title":"Amiodarone kinetics after oral doses","volume":"31","author":"Kannan","year":"1982","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.molpha.2025.100094_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jelectrocard.2010.04.007","article-title":"Characterization of recombinant hERG K+ channel inhibition by the active metabolite of amiodarone desethyl-amiodarone","volume":"43","author":"Zhang","year":"2010","journal-title":"J Electrocardiol"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjp.2008.325","article-title":"Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs","volume":"155","author":"McPate","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2004.10.127","article-title":"High affinity HERG K+ channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656","volume":"325","author":"Ridley","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molpha.2025.100094_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2016.05.013","article-title":"Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking","volume":"113","author":"Zhang","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/PL00005344","article-title":"Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels","volume":"359","author":"Kiehn","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100094_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1085\/jgp.200609500","article-title":"Na+ permeation and block of hERG potassium channels","volume":"128","author":"Gang","year":"2006","journal-title":"J Gen Physiol"},{"issue":"5259","key":"10.1016\/j.molpha.2025.100094_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.molpha.2025.100094_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bjp.0706892","article-title":"Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine","volume":"149","author":"Rajamani","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/jpet.107.120931","article-title":"Identification of IKr and its trafficking disruption induced by Probucol in cultured neonatal rat cardiomyocytes","volume":"321","author":"Guo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.106.113043","article-title":"Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking","volume":"320","author":"Wang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/mol.111.075135","article-title":"Molecular determinants of pentamidine-induced hERG trafficking inhibition","volume":"81","author":"Dennis","year":"2012","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100094_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/mol.66.1.33","article-title":"Mechanisms of arsenic-induced prolongation of cardiac repolarization","volume":"66","author":"Ficker","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.molpha.2025.100094_bib36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1096\/fj.201700832R","article-title":"Glycosylation stabilizes hERG channels on the plasma membrane by decreasing proteolytic susceptibility","volume":"32","author":"Lamothe","year":"2018","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.molpha.2025.100094_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature","volume":"74","author":"Zhou","year":"1998","journal-title":"Biophys J"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib38","doi-asserted-by":"crossref","first-page":"H1278","DOI":"10.1152\/ajpheart.00777.2005","article-title":"Specific serine proteases selectively damage KCNH2 (hERG1) potassium channels and IKr","volume":"290","author":"Rajamani","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"39","key":"10.1016\/j.molpha.2025.100094_bib39","doi-asserted-by":"crossref","first-page":"20387","DOI":"10.1074\/jbc.M116.743138","article-title":"The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage","volume":"291","author":"Lamothe","year":"2016","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.molpha.2025.100094_bib40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jat.3074","article-title":"Assessment of temperature-induced hERG channel blockade variation by drugs","volume":"35","author":"Kauthale","year":"2015","journal-title":"J Appl Toxicol"},{"issue":"22","key":"10.1016\/j.molpha.2025.100094_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216261","article-title":"Facilitation of hERG activation by its blocker: a mechanism to reduce drug-induced proarrhythmic risk","volume":"24","author":"Furutani","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10.1016\/j.molpha.2025.100094_bib42","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0026-895X(24)23209-0","article-title":"Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites","volume":"57","author":"Lees-Miller","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2025.100094_bib44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/mol.63.5.1051","article-title":"Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain","volume":"63","author":"S\u0103nchez-Chapula","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"26","key":"10.1016\/j.molpha.2025.100094_bib45","doi-asserted-by":"crossref","first-page":"23587","DOI":"10.1074\/jbc.M200448200","article-title":"Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block","volume":"277","author":"S\u00e1nchez-Chapula","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/mol.60.2.244","article-title":"Open channel block of HERG K+ channels by vesnarinone","volume":"60","author":"Kamiya","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"19","key":"10.1016\/j.molpha.2025.100094_bib47","doi-asserted-by":"crossref","first-page":"12461","DOI":"10.1073\/pnas.192367299","article-title":"Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1085\/jgp.201010582","article-title":"hERG potassium channel gating is mediated by N- and C-terminal region interactions","volume":"137","author":"Gustina","year":"2011","journal-title":"J Gen Physiol"},{"issue":"8","key":"10.1016\/j.molpha.2025.100094_bib49","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.cellsig.2012.04.004","article-title":"HERG potassium channel regulation by the N-terminal eag domain","volume":"24","author":"Gustina","year":"2012","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.molpha.2025.100094_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107526","article-title":"Rescue of expression and function of long QT syndrome-causing mutant hERG channels by enhancing channel stability in the plasma membrane","volume":"300","author":"Davis","year":"2024","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.molpha.2025.100094_bib51","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1161\/01.RES.0000079028.31393.15","article-title":"Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG","volume":"92","author":"Ficker","year":"2003","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.molpha.2025.100094_bib52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1085\/jgp.115.3.229","article-title":"Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate","volume":"115","author":"Mitcheson","year":"2000","journal-title":"J Gen Physiol"},{"issue":"9","key":"10.1016\/j.molpha.2025.100094_bib54","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI39027","article-title":"Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines","volume":"119","author":"Guo","year":"2009","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib55","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.109.215970","article-title":"Extracellular K+ is a prerequisite for the function and plasma membrane stability of HERG channels","volume":"106","author":"Massaeli","year":"2010","journal-title":"Circ Res"},{"issue":"40","key":"10.1016\/j.molpha.2025.100094_bib56","doi-asserted-by":"crossref","first-page":"34664","DOI":"10.1074\/jbc.M111.253351","article-title":"Interaction between the cardiac rapidly (IKr) and slowly (IKs) activating delayed rectifier potassium channels revealed by low K+-induced hERG endocytic degradation","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.molpha.2025.100094_bib57","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-9149(84)90524-1","article-title":"Plasma and red blood cell concentrations of amiodarone during chronic therapy","volume":"53","author":"Heger","year":"1984","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib58","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1067\/mcp.2000.107047","article-title":"Population pharmacokinetics of long-term oral amiodarone therapy","volume":"67","author":"Pollak","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.molpha.2025.100094_bib59","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2125.1988.tb05311.x","article-title":"Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method","volume":"26","author":"Veronese","year":"1988","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.molpha.2025.100094_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0002-8703(87)90492-3","article-title":"Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels","volume":"114","author":"Kannan","year":"1987","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.molpha.2025.100094_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-9149(85)90572-7","article-title":"Value of hepatic computerized tomographic scanning during amiodarone therapy","volume":"56","author":"Markos","year":"1985","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100094_bib62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0735-1097(86)80272-8","article-title":"QT prolongation and the antiarrhythmic efficacy of amiodarone","volume":"7","author":"Torres","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib63","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcp.12726","article-title":"Pharmacological treatment of acquired QT prolongation and torsades de pointes","volume":"81","author":"Thomas","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.molpha.2025.100094_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12810","article-title":"Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy","volume":"26","author":"Yonai","year":"2021","journal-title":"Ann Noninvasive Electrocardiol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25157544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25157544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:34:58Z","timestamp":1777426498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25157544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0026895X25157544"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100094","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone irrecoverably impairs the function of human ether-a-go-go-related gene potassium channels","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100094"}}